98%
921
2 minutes
20
Background And Objectives: This paper introduces a novel lightweight MM-3DUNet (Multi-task Mobile 3D UNet) network designed for efficient and accurate segmentation of breast cancer tumors masses from MRI images, which leverages depth-wise separable convolutions, channel expansion units, and auxiliary classification tasks to enhance feature representation and computational efficiency.
Methods: We propose a 3D depth-wise separable convolution, and construct channel expansional convolution (CEC) unit and inverted residual block (IRB) to reduce the parameter count and computational load, making the network more suitable for use in resource-constrained environments. In addition, an auxiliary classification task (ACT) is introduced in the proposed architecture to provide additional supervisory signals for the main task of segmentation. The network architecture features a contracting path for downsampling and an expanding path for precise localization, enhanced by skip connections that integrate multi-level semantic information.
Results: The network was evaluated using a dataset of Dynamic Contrast Enhanced MRI (DCE-MRI) breast cancer images, and the results show that compared to the classical 3DU-Net, MM-3DUNet could significantly reduce model parameters by 63.16% and computational demands by 80.90%, while increasing segmentation accuracy by 1.30% in IoU (Intersection over Union).
Conclusions: MM-3DUNet offers a substantial reduction in computational requirements of breast cancer mass segmentation network. This network not only enhances diagnostic precision but also supports deployment in diverse clinical settings, potentially improving early detection and treatment outcomes for breast cancer patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12106037 | PMC |
http://dx.doi.org/10.3389/fonc.2025.1563959 | DOI Listing |
Stem Cell Rev Rep
September 2025
Paris Cité University, INSERM UMR-S 970, Paris Cardiovascular Research Centre, Paris, France.
Endothelial Colony-Forming Cells (ECFCs) are recognized as key vasculogenic progenitors in humans and serve as valuable liquid biopsies for diagnosing and studying vascular disorders. In a groundbreaking study, Anceschi et al. present a novel, integrative strategy that combines ECFCs loaded with gold nanorods (AuNRs) to enhance tumor radiosensitization through localized hyperthermia.
View Article and Find Full Text PDFAnn Surg Oncol
September 2025
Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Ann Surg Oncol
September 2025
Department of Surgery, Division of Surgical Oncology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
Ann Surg Oncol
September 2025
Department of General Surgery, Abdulkadir Yuksel State Hospital, Gaziantep, Turkey.
Breast Cancer Res Treat
September 2025
Department of Pharmacy, Duke University Hospital, Durham, NC, USA.
Purpose: Limited data is available assessing sequencing of antibody drug conjugates (ADCs) in patients with hormone receptor-positive (HR +), human epidermal growth factor 2 (HER2)-negative, HER2-low, and triple-negative metastatic breast cancer (MBC), including patients with brain metastases (BrM) or leptomeningeal disease (LMD). This study assesses the efficacy and safety of sequential sacituzumab govitecan (SG) and trastuzumab deruxtecan (T-DXd) in MBC and impact on chemotherapy (CTX).
Methods: This is a single-center, retrospective, cohort study in adult patients with HR + , HER2-negative, or low MBC who received T-DXd and/or SG.